Scott Schoenhaus
Stock Analyst at Keybanc
(2.09)
# 2,875
Out of 4,941 analysts
112
Total ratings
38.78%
Success rate
-5.27%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Overweight | $14 → $12 | $6.83 | +75.70% | 4 | Aug 6, 2025 | |
| SLP Simulations Plus | Downgrades: Sector Weight | n/a | $14.18 | - | 5 | Jul 15, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $45 → $60 | $55.99 | +7.16% | 2 | Jul 14, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $106 → $93 | $63.42 | +46.64% | 1 | Jul 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $70 | $61.82 | +13.23% | 4 | Jul 14, 2025 | |
| CERT Certara | Maintains: Overweight | $18 → $15 | $10.75 | +39.53% | 5 | Jul 14, 2025 | |
| ALB Albemarle | Maintains: Overweight | $95 → $87 | $77.98 | +11.57% | 1 | Jul 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $5 → $10 | $4.27 | +134.19% | 6 | Jul 14, 2025 | |
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $18.85 | +69.76% | 5 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $27.85 | +0.54% | 7 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $52 → $50 | $60.20 | -16.94% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $92.98 | +7.55% | 5 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $3.00 | +66.67% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $9 | $2.97 | +203.03% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $275.43 | -7.42% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $5.41 | +84.84% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $3.50 | +71.43% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.50 | +80.00% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $3.83 | +187.21% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.75 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $31.54 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $6.87 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $185.91 | +34.47% | 2 | Apr 16, 2021 |
LifeMD
Aug 6, 2025
Maintains: Overweight
Price Target: $14 → $12
Current: $6.83
Upside: +75.70%
Simulations Plus
Jul 15, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $14.18
Upside: -
Hinge Health
Jul 14, 2025
Maintains: Overweight
Price Target: $45 → $60
Current: $55.99
Upside: +7.16%
Eastman Chemical Company
Jul 14, 2025
Maintains: Overweight
Price Target: $106 → $93
Current: $63.42
Upside: +46.64%
Doximity
Jul 14, 2025
Maintains: Overweight
Price Target: $65 → $70
Current: $61.82
Upside: +13.23%
Certara
Jul 14, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $10.75
Upside: +39.53%
Albemarle
Jul 14, 2025
Maintains: Overweight
Price Target: $95 → $87
Current: $77.98
Upside: +11.57%
AbCellera Biologics
Jul 14, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $4.27
Upside: +134.19%
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $18.85
Upside: +69.76%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $27.85
Upside: +0.54%
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $60.20
Upside: -16.94%
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $92.98
Upside: +7.55%
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.00
Upside: +66.67%
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.97
Upside: +203.03%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $275.43
Upside: -7.42%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $5.41
Upside: +84.84%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $3.50
Upside: +71.43%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.50
Upside: +80.00%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $3.83
Upside: +187.21%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $21.75
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $31.54
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $6.87
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $185.91
Upside: +34.47%